C1抑制物基因突变提前形成终止密码子导致遗传性血管水肿

摘要

目的 检测7例来自不同遗传性血管水肿家系患者进行C1抑制物(C1 inhibitor,C1 INH)基因突变.方法 2011 至2012年北京协和医院变态反应科诊断为Ⅰ型HAE的7例来自不同HAE家系的先证者及53名健康成人为研究对象,采集外周静脉血,提取基因组DNA,聚合酶链反应扩增C1 INH基因的8个外显子及其相邻序列并进行序列检测.将检测结果与GenBank公布的C1 INH 基因序列相比较,确定突变及基因多态性.结果 7例患者C1 INH基因序列中均鉴定到致病突变,分别为c.289 CA,g.3248T>C,g.3493T>C,g.5755 G>A,g.9498 T>C,g.15193 A>G,g.18012 G>A.结论 本研究鉴定的7种不同C1 INH基因突变中有5种为国内外首次报道,丰富了中国C1 INH基因突变数据库.%Objective To detect C1 inhibitor gene mutations in 7 HAE patients from different families. Methods Seven HAE patients with from different families and 53 healthy controls were recruited in this study. Peripheral blood was collected for genome DNA extraction. All the eight exons and intron-exon boundaries of Cl inhibitor gene were amplified by PCR and sequenced. Mutations and SNPs were detected by alignment with the reference sequences from GenBank. Results Mutations were identified in all the 7 patients: c. 289 C < T, c. 538 C A, g. 3248T>C, g. 3493T > C, g. 5755 G > A, g. 9498 T > C, g. 15193 A > G, g. 18012 G > A) . Conclusions Totally 7 different mutations of Cl-INH gene (3 nonsense and 4 frame shift) were detected in 7 HAE patients, 5 of them were reported for the first time. 7 SNPs were also identified in this patient group.